Free Trial
NYSEAMERICAN:VTAK

Catheter Precision (VTAK) Stock Price, News & Analysis

Catheter Precision logo
$2.52 -0.06 (-2.33%)
As of 10:02 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Catheter Precision Stock (NYSEAMERICAN:VTAK)

Key Stats

Today's Range
$2.49
$2.56
50-Day Range
$2.45
$6.20
52-Week Range
$2.39
$42.75
Volume
4,509 shs
Average Volume
679,928 shs
Market Capitalization
$3.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Catheter Precision Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

VTAK MarketRank™: 

Catheter Precision scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Catheter Precision.

  • Earnings Growth

    Earnings for Catheter Precision are expected to grow in the coming year, from ($8.90) to ($6.30) per share.

  • Price to Book Value per Share Ratio

    Catheter Precision has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Catheter Precision's valuation and earnings.
  • Percentage of Shares Shorted

    3.19% of the float of Catheter Precision has been sold short.
  • Short Interest Ratio / Days to Cover

    Catheter Precision has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Catheter Precision has recently increased by 1.87%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Catheter Precision does not currently pay a dividend.

  • Dividend Growth

    Catheter Precision does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.19% of the float of Catheter Precision has been sold short.
  • Short Interest Ratio / Days to Cover

    Catheter Precision has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Catheter Precision has recently increased by 1.87%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Catheter Precision has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Catheter Precision this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for VTAK on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Catheter Precision to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Catheter Precision insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.95% of the stock of Catheter Precision is held by insiders.

  • Percentage Held by Institutions

    Only 20.34% of the stock of Catheter Precision is held by institutions.

  • Read more about Catheter Precision's insider trading history.
Receive VTAK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Catheter Precision and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VTAK Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
See More Headlines

VTAK Stock Analysis - Frequently Asked Questions

Catheter Precision's stock was trading at $8.5329 at the beginning of the year. Since then, VTAK shares have decreased by 69.8% and is now trading at $2.5760.

Catheter Precision shares reverse split on Monday, August 18th 2025.The 1-19 reverse split was announced on Friday, August 15th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 15th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of VTAK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Catheter Precision investors own include ARMOUR Residential REIT (ARR), Jiuzi (JZXN), Windtree Therapeutics (WINT), AMC Entertainment (AMC), Sphere 3D (ANY), BioCardia (BCDA) and Chemomab Therapeutics (CMMB).

Company Calendar

Today
8/29/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSEAMERICAN:VTAK
CIK
1716621
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.64 million
Net Margins
-3,150.33%
Pretax Margin
-2,964.00%
Return on Equity
-193.63%
Return on Assets
-72.09%

Debt

Debt-to-Equity Ratio
0.19
Current Ratio
0.44
Quick Ratio
0.43

Sales & Book Value

Annual Sales
$420 thousand
Price / Sales
7.54
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.34 per share
Price / Book
0.48

Miscellaneous

Outstanding Shares
1,230,000
Free Float
1,191,000
Market Cap
$3.17 million
Optionable
N/A
Beta
-0.65
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NYSEAMERICAN:VTAK) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners